The report titled “Digital Therapeutics Market: Opportunity Analysis and Future Assessment 2022-2030” freshly published by Reports & Insights has the primary objective to offer its clients outright in-depth and meticulous information about the respective market along with the thorough knowledge of the statistics oriented in the direction of development of the respective market. For a clearer picture of the readers, the report also offers comprehensive know-how of the market, conceptual structure, and prevailing trends of the market together with the detailed textual and graphical representation. In addition, the report also cites comprehensively about the key players competing in the market for the unfluctuating intrigue of its readers.
The global digital therapeutics market in 2022 is estimated for more than US$ 3.7 Bn and expected to reach a value of US$ 22.9 Bn by 2030 with a significant CAGR of 25.8%.
Access Sample Copy of “Digital Therapeutics Market Report”: https://reportsandinsights.com/sample-request/1123
Digital Therapeutics Introduction
The digital Therapeutics market includes a couple of segments such as application and end-use. The application segment further divided into six other categories such as diabetes, obesity, CVD, CNS, respiratory, and others. The end-user segment is further divided into patients, caregivers, employers, payers, and pharmaceutical companies.
Furthermore, the study includes market estimation, market forecast, and market information for six geographical regions around the globe. In 2016, in the U.S. diabetes is the seventh major cause of death, which affects around 10% of the U.S. population that is around 30.0 million and around 95% of diabetic patients have type 2 diabetes that is significantly associated with behavioral factors such as heavy calorie intake and less physical activity.
Digital Therapeutics Market Dynamics
In the healthcare system diabetes costs around US$ 245 Bn annually of which around US$ 176 Bn is included under direct medical costs. Medical management under digital therapeutics for the patients includes a change in diet recommendations, physical activities and smoking cessation, oral anti-diabetic agents, insulin therapy, and complication preventions that are linked with diabetes, such as cardiovascular risk factor management.
Change in demographics is one of the important aspects for the growth in the health care industry as most of the countries are experiencing a high percentage of transformation in the young population into the aged population. According to World Bank Data, in 2013, the total healthcare spending globally was $7.2 trillion, which accounts for around 11.0% of global GDP and expected to grow at more than 5.0% annually to 2018. The result of global healthcare spending leads to an increase in life expectancy that leads to an aging population.
Furthermore, the UN forecasts that the global share of the population over the age of 60 is expected to increase from 11.7% in 2013 to 21.1% in 2050, with rise in chronic ailments, which in turn is expected to favor the market for digital therapeutics market in the near future.
View Report Details Before Purchasing – https://reportsandinsights.com/report/global-digital-therapeutics-market
Digital Therapeutics Market Segmentation
The digital therapeutics market is segmented on the basis of application, end-use, and region.
By Application
- Preventive Applications
o Prediabetes
o Obesity
o Nutrition
o Lifestyle Management
o Others
- Treatment Applications
o Diabetes
o CNS Disorders
o Chronic Respiratory Disorders
o Musculoskeletal Disorders
o Cardiovascular Diseases
o Smoking Cessation
o Medication Adherence
o Gastrointestinal Disorders
o Substance Use & Addiction Management
o Rehabilitation & Patient Care
o Others
By End-Use
Patients
Caregivers
Employers
Payers
Pharmaceutical Companies
The rise in digital education and ease in data quantification in the life science and biotechnology industry is the first and foremost factor driving demand for digital therapeutics in the global market. Increasing research and development activities in therapeutic industries would further increase the demand for more use of digital therapeutics. Technological advancements in various therapies is one of the main factor driving the growth of this market.
Digital Therapeutics Market Key Players
The global digital therapeutics market is mainly dominated by Omada Health, NeuroTrack Technologies, Inc., ZappRx, MEDIMETRICS, Arthro Therapeutics, BiogeniQ, Oviva AG, Healark, Pathology Diagnostics Ltd., between MD, LLC.
To view Top Players, Segmentation and other Statistics of Digital Therapeutics Industry, Get Sample Report: @ https://reportsandinsights.com/sample-request/1123
About Reports and Insights:
Reports and Insights is one of the leading market research company which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Contact Us:
Neil Jonathan
1820 Avenue M, Brooklyn
NY 11230, United States
+1-(718) 312-8686
Find Us on Linkedin: www.linkedin.com/company/report-and-insights/
View Latest Market Updates at: https://marketsresearchanalytics.com